Cargando…

Influenza Virus Infects and Depletes Activated Adaptive Immune Responders

Influenza infections cause several million cases of severe respiratory illness, hospitalizations, and hundreds of thousands of deaths globally. Secondary infections are a leading cause of influenza's high morbidity and mortality, and significantly factored into the severity of the 1918, 1968, a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bohannon, Caitlin D., Ende, Zachary, Cao, Weiping, Mboko, Wadzanai P., Ranjan, Priya, Kumar, Amrita, Mishina, Margarita, Amoah, Samuel, Gangappa, Shivaprakash, Mittal, Suresh K., Lovell, Jonathan F., García‐Sastre, Adolfo, Pfeifer, Blaine A., Davidson, Bruce A., Knight, Paul, Sambhara, Suryaprakash
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8373117/ https://www.ncbi.nlm.nih.gov/pubmed/34189857 http://dx.doi.org/10.1002/advs.202100693

Ejemplares similares

Nasal delivery of H5N1 avian influenza vaccine formulated with GenJet™ or in vivo-jetPEI(®) induces enhanced serological, cellular and protective immune responses
por: Cao, Weiping, et al.
Publicado: (2018)

Influenza virus exploits tunneling nanotubes for cell-to-cell spread
por: Kumar, Amrita, et al.
Publicado: (2017)

A Dual-Functioning 5ʹ-PPP-NS1shRNA that Activates a RIG-I Antiviral Pathway and Suppresses Influenza NS1
por: Singh, Neetu, et al.
Publicado: (2020)

A Bovine Adenoviral Vector-Based H5N1 Influenza -Vaccine Provides Enhanced Immunogenicity and Protection at a Significantly Low Dose
por: Sayedahmed, Ekramy E., et al.
Publicado: (2018)

Adenovirus vector-based multi-epitope vaccine provides partial protection against H5, H7, and H9 avian influenza viruses
por: Hassan, Ahmed O., et al.
Publicado: (2017)

Quinazolin-derived myeloperoxidase inhibitor suppresses influenza A virus-induced reactive oxygen species, pro-inflammatory mediators and improves cell survival
por: De La Cruz, Juan A., et al.
Publicado: (2021)

Innate lymphoid cells (ILC) in SARS-CoV-2 infection()
por: Kumar, Amrita, et al.
Publicado: (2021)

Nasal delivery of Protollin-adjuvanted H5N1 vaccine induces enhanced systemic as well as mucosal immunity in mice
por: Cao, Weiping, et al.
Publicado: (2017)

5'PPP-RNA induced RIG-I activation inhibits drug-resistant avian H5N1 as well as 1918 and 2009 pandemic influenza virus replication
por: Ranjan, Priya, et al.
Publicado: (2010)

NADPH Oxidase 1 Is Associated with Altered Host Survival and T Cell Phenotypes after Influenza A Virus Infection in Mice
por: Hofstetter, Amelia R., et al.
Publicado: (2016)

The 3′ Untranslated Regions of Influenza Genomic Sequences Are 5′PPP-Independent Ligands for RIG-I
por: Davis, William G., et al.
Publicado: (2012)

Effect of Repeat Vaccination on Immunogenicity of Quadrivalent Cell-Culture and Recombinant Influenza Vaccines Among Healthcare Personnel Aged 18–64 Years: A Randomized, Open-Label Trial
por: Gaglani, Manjusha, et al.
Publicado: (2022)

Immunogenicity of High-Dose Egg-Based, Recombinant, and Cell Culture–Based Influenza Vaccines Compared With Standard-Dose Egg-Based Influenza Vaccine Among Health Care Personnel Aged 18–65 Years in 2019–2020
por: Naleway, Allison L, et al.
Publicado: (2023)

Progress towards the Development of a Universal Influenza Vaccine
por: Wang, Wen-Chien, et al.
Publicado: (2022)

Adenoviral Vector-Based Vaccine Platforms for Developing the Next Generation of Influenza Vaccines
por: Sayedahmed, Ekramy E., et al.
Publicado: (2020)

Adenoviral vector‐based platforms for developing effective vaccines to combat respiratory viral infections
por: Elkashif, Ahmed, et al.
Publicado: (2021)

Immunosenescence and Influenza Vaccine Efficacy
por: Sambhara, Suryaprakash, et al.
Publicado: (2009)

Non-neutralizing antibodies induced by seasonal influenza vaccine prevent, not exacerbate A(H1N1)pdm09 disease
por: Kim, Jin Hyang, et al.
Publicado: (2016)

Discovery of Retro-1 Analogs Exhibiting Enhanced Anti-vaccinia Virus Activity
por: Priyamvada, Lalita, et al.
Publicado: (2020)

Immunogenicity of standard, high-dose, MF59-adjuvanted, and recombinant-HA seasonal influenza vaccination in older adults
por: Li, Athena P. Y., et al.
Publicado: (2021)

Broadly Protective Adenovirus-Based Multivalent Vaccines against Highly Pathogenic Avian Influenza Viruses for Pandemic Preparedness
por: Vemula, Sai V., et al.
Publicado: (2013)

Human Heat shock protein 40 (Hsp40/DnaJB1) promotes influenza A virus replication by assisting nuclear import of viral ribonucleoproteins
por: Batra, Jyoti, et al.
Publicado: (2016)

Impact of Preexisting Adenovirus Vector Immunity on Immunogenicity and Protection Conferred with an Adenovirus-Based H5N1 Influenza Vaccine
por: Pandey, Aseem, et al.
Publicado: (2012)

An ELISA-based method for detection of rabies virus nucleoprotein-specific antibodies in human antemortem samples
por: Realegeno, Susan, et al.
Publicado: (2018)

Challenges for vaccination in the elderly
por: Aspinall, Richard, et al.
Publicado: (2007)

Patients Hospitalized with pH1N1 Influenza in an Academic Community Medical Center
por: Bergman, Hagit, et al.
Publicado: (2011)

Antibody-Independent Control of γ-Herpesvirus Latency via B Cell Induction of Anti-Viral T Cell Responses
por: McClellan, Kelly B, et al.
Publicado: (2006)

Heterogeneous Ribonucleoprotein A1 (hnRNPA1) Interacts with the Nucleoprotein of the Influenza a Virus and Impedes Virus Replication
por: Kaur, Ramandeep, et al.
Publicado: (2022)

Pathogenic virus-specific T cells cause disease during treatment with the calcineurin inhibitor FK506: implications for transplantation
por: Araki, Koichi, et al.
Publicado: (2010)

Conserved Oligomeric Golgi (COG) Complex Proteins Facilitate Orthopoxvirus Entry, Fusion and Spread
por: Realegeno, Susan, et al.
Publicado: (2020)

Identification of the In Vivo Role of a Viral bcl-2
por: Gangappa, Shivaprakash, et al.
Publicado: (2002)

Influenza A Virus Nucleoprotein Exploits Hsp40 to Inhibit PKR Activation
por: Sharma, Kulbhushan, et al.
Publicado: (2011)

Significant Impact of Sequence Variations in the Nucleoprotein on CD8 T Cell-Mediated Cross-Protection against Influenza A Virus Infections
por: Zhong, Weimin, et al.
Publicado: (2010)

Influenza A Virus Nucleoprotein Activates the JNK Stress-Signaling Pathway for Viral Replication by Sequestering Host Filamin A Protein
por: Sharma, Anshika, et al.
Publicado: (2020)

Tryptophan Depletion Promotes Habitual over Goal-Directed Control of Appetitive Responding in Humans
por: Worbe, Yulia, et al.
Publicado: (2015)

Age, serum 25-hydroxyvitamin D and vitamin D receptor (VDR) expression and function in peripheral blood mononuclear cells
por: Coleman, Laura A., et al.
Publicado: (2016)

Note: Mayday, Mayday, Mayday! Responding to environmental shocks: Insights on global airlines’ responses to COVID-19
por: Amankwah-Amoah, Joseph
Publicado: (2020)

The Dinoflagellate Lingulodinium polyedrum Responds to N Depletion by a Polarized Deposition of Starch and Lipid Bodies
por: Dagenais Bellefeuille, Steve, et al.
Publicado: (2014)

Antigen-specific precursor frequency impacts T cell proliferation, differentiation, and requirement for costimulation
por: Ford, Mandy L., et al.
Publicado: (2007)

Responder T cells depleted of alloreactive cells react to antigen presented on allogeneic macrophages from nonresponder strains
Publicado: (1981)

Cannot write session to /tmp/vufind_sessions/sess_2eb73potu05dl0jn5s10ucpngs